Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels

MLA

Franco Rubino, et al. “Prognostic Molecular Biomarkers in Chordomas: A Systematic Review and Identification of Clinically Usable Biomarker Panels.” Frontiers in Oncology, vol. 12, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e05599832be2f8f52f22d3d1fac2c7fd&authtype=sso&custid=ns315887.

APA

Franco Rubino, Christopher Alvarez-Breckenridge, Kadir Akdemir, Anthony P. Conley, Andrew J. Bishop, Wei-Lien Wang, Alexander J. Lazar, Laurence D. Rhines, Franco DeMonte, & Shaan M. Raza. (2022). Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels. Frontiers in Oncology, 12.

Chicago

Franco Rubino, Christopher Alvarez-Breckenridge, Kadir Akdemir, Anthony P. Conley, Andrew J. Bishop, Wei-Lien Wang, Alexander J. Lazar, Laurence D. Rhines, Franco DeMonte, and Shaan M. Raza. 2022. “Prognostic Molecular Biomarkers in Chordomas: A Systematic Review and Identification of Clinically Usable Biomarker Panels.” Frontiers in Oncology 12 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e05599832be2f8f52f22d3d1fac2c7fd&authtype=sso&custid=ns315887.